Comparison Between Single-port and Three-port Video-assisted Thoracoscopic Lobectomy in the Treatment of Lung Cancer
10.3969/j.issn.1009-6604.2018.03.004
- VernacularTitle:单操作孔完全胸腔镜与传统三孔胸腔镜治疗肺癌的疗效比较
- Author:
Yu LIU
1
;
Xuebing SONG
;
Wulin ZHANG
Author Information
1. 邯郸市中心医院胸外科
- Keywords:
Uniportal complete thoracoscopy;
Three-port thoracoscopy;
Lung cancer
- From:
Chinese Journal of Minimally Invasive Surgery
2018;18(3):205-208
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical efficacy of uniportal complete thoracoscopic and conventional three -port thoracoscopic lobectomy in the treatment of lung cancer. Methods A total of 62 cases of lung cancer from January 2012 to January 2016 received lobectomy in our hospital.According to admission sequence number, the patients were randomly divided into either single-port group(n=31)or three-port group(n=31).The single-port group was given uniportal thoracoscopic lobectomy, and the three-port group was given traditional three-port operation of VATS lobectomy.We compared the two groups with intraoperative and postoperative conditions and follow-up outcomes. Results The operations were successfully completed in both groups.There were no significant differences between the two groups in operation time[(182.3 ±77.9)min vs.(177.6 ±69.2)min, t =0.251, P=0.803],intraoperative blood loss[(207.3 ±48.4)ml vs.(226.5 ±52.3)ml,t=-1.500, P=0.139], chest tube indwelling time[(5.5 ±1.6)d vs.(5.7 ±2.0)d, t=0.435, P=0.665], postoperative hospitalization time[(8.7 ±2.7)d vs.(9.0 ± 2.8)d,t=0.925,P=0.0.372],lymph node dissection number[(11.2 ±2.8)vs.(11.7 ±3.1),t=-0.666,P=0.508]and postoperative incidence of complications[9.7%(3/31)vs.12.9%(4/31),χ2=0.000,P=1.000].The VAS scores on the first and fifth postoperative day were(3.1 ±1.1)points and(1.0 ±0.7)points in the single-port group, which were significantly lower than those in the three-port group[(3.9 ±1.4)points,t=-2.502,P=0.015;(1.5 ±0.7)points,t=-2.812,P=0.007].The 62 cases were followed up for 12-36 months(mean,18.4 ±6.4 months)without recurrence and death. Conclusion Single-port thoracoscopic lobectomy for lung cancer has good curative effect and safety as compared with traditional method,being worthy of clinical application.
